Status:
COMPLETED
Pancreatic Calcium Handling in Islet Beta Cells in Patients With Type 1 Diabetes Mellitus
Lead Sponsor:
University of Edinburgh
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Approximately 400,000 people are living with type 1 diabetes mellitus (T1DM) in the United Kingdom: one of the highest rates in the world. It is characterised by autoimmune loss of pancreatic beta cel...
Eligibility Criteria
Inclusion
- Age \>18 years
- No regular medications
- No known significant medical conditions
Exclusion
- Inability to consent
- Renal failure (eGFR \<30 mL/min/1.73 m2)
- Standard MRI contraindications
- Pregnancy or breast feeding
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05298735
Start Date
March 1 2021
End Date
January 31 2022
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh
Edinburgh, Scotland, United Kingdom